Executive Branch

Rod Rosenstein Closed-Door Interview Abruptly Postponed
Deputy AG had been slated to appear before leadership of Judiciary, Oversight panels

Deputy Attorney General Rod Rosenstein will not be testifying before the leadership of the House Judiciary and Oversight committees after the GOP chairmen abruptly postponed the meeting. (Bill Clark/CQ Roll Call file photo)

Deputy Attorney General Rod Rosenstein’s highly anticipated interview on Capitol Hill has been postponed, the chairmen of two House oversight committees announced late Tuesday, punting a high-profile event scheduled for Wednesday to an unknown date. 

“The Committees are unable to ask all questions of Deputy Attorney General Rod Rosenstein within the time allotted for tomorrow’s transcribed interview, therefore, the interview will be postponed. Mr. Rosenstein has indicated his willingness to testify before the Judiciary and Oversight Committees in the coming weeks in either a transcribed interview or a public setting,” Judiciary Chairman Robert W. Goodlatte and Oversight and Government Reform Chairman Trey Gowdy said in a joint statement.

What Could Have Been: 3 Expectations for Rod Rosenstein’s Canceled Meeting With Lawmakers
Quick turnaround time for the transcript, a possible new investigative precedent for the panel, and angry House conservatives

Deputy Attorney General Rod Rosenstein will meet with lawmakers behind closed doors Wednesday regarding comments he allegedly made about secretly recording President Donald Trump. (Tom Williams/CQ Roll Call file photo)

Updated | After weeks of contentious back-and-forth between House GOP lawmakers and Rod Rosenstein, the deputy attorney general was finally set to answer some questions about comments he allegedly made about covertly recording President Donald Trump — until a last-minute postponement, that is, put off the highly anticipated sit-down. 

Rosenstein, who appears to have patched up his relationship with the president after reportedly preparing late last month to tender his resignation, was to field questions from just four leaders on the joint Judiciary and Oversight and Government Reform panel — Republican Chairmen Bob Goodlatte and Trey Gowdy and Democratic ranking members Jerrold Nadler and Elijah Cummings.

What Will Trump Do About Khashoggi? ‘Leave It Up to Congress’
President likely won’t stop arms sales to Saudi Arabia, he says

A protester dressed as Saudi Arabian crown prince Mohammad bin Salman and another dressed as President Donald Trump demonstrate outside the White House last week. (Win McNamee/Getty Images)

President Donald Trump said Tuesday he will leave much of the U.S. response to the death of Jamal Khashoggi in the hands of Congress, calling Saudi Arabia’s efforts to muddy what happened to the Washington Post journalist “the worst cover-up ever.”

Meanwhile, Secretary of State Mike Pompeo announced the Trump administration is revoking visas for some Saudi officials believed to be involved in Khashoggi’s death.

Brady Says Ways and Means Will Work With Trump on 10 Percent Middle-Class Tax Cut
Tax writing chairman’s statement comes after Trump already suggested Brady was working on it

House Ways and Means Chairman Kevin Brady, R-Texas, says his panel will work with President Donald Trump and his administration to craft the mysterious 10 percent middle-class tax cut bill the president has been talking about lately. (Bill Clark/CQ Roll Call)

President Donald Trump must’ve spent some time offstage Monday night in Houston talking up his new middle-class tax cut idea to Ways and Means Chairman Kevin Brady, because the House chief’s tax writer has agreed to take on the project. 

In recent days Trump has started talking about working with Congress on new tax cut legislation focused on providing further relief to the middle-class. He initially said a measure would be unveiled before November 1, revised that to after the election and then reversed the time back to next week.

Senate GOP Forges Ahead With Judicial Nominations Despite More Democratic Opposition
Sen. Patty Murray is against Wednesday hearing for a home state nominee

Assistant Minority Leader Patty Murray opposes holding a hearing on a judicial nominee from her home state while the Senate is away. Senate Judiciary Chairman Charles E. Grassley does not seem to care. (Sarah Silbiger/CQ Roll Call file photo)

The Senate is still away, but its Judiciary Committee keeps plugging away.

The panel is scheduled to hold another likely sparsely attended confirmation hearing on Wednesday to hear from more of President Donald Trump’s judicial nominees, including a Ninth U.S. Circuit Court of Appeals selection opposed by home-state Democratic senators.

Sandra Day O’Connor Leaves a Political and Judicial Legacy
First woman on the Supreme Court was a skilled legislator in Grand Canyon State

Former Supreme Court Justice Sandra Day O’Connor testifies during the Senate Judiciary Committee hearing on “Ensuring Judicial Independence Through Civics Education” on Wednesday, July 25, 2012. (Bill Clark/CQ Roll Call file photo)

Sandra Day O’Connor’s announcement Tuesday that she was stepping away from public life brings into stark relief not just the legacy of the first woman to serve on the Supreme Court, but that of a fading model for what a justice could be: a politician actively engaged in the civic arena.

Citing a dementia diagnosis that would most likely progress to Alzheimer’s disease, the 88-year-old said she was “no longer able to participate in public life,” something that defined her career. 

Democrats Press Dan Coats for Details of Trump’s Chinese Election Meddling Claims
Members of the Senate Intelligence Committee ask if intelligence community will back the president

Sen. Ron Wyden is leading a request for intelligence about Chinese election meddling. (Bill Clark/CQ Roll Call file photo)

Three Democratic members of the Senate Intelligence Committee want to know whether the actual intelligence backs up President Donald Trump’s claims of election meddling by the Chinese.

“We are writing with regard to President Trump’s most recent comments on foreign interference in U.S. elections, wrote Sens. Ron Wyden of Oregon, Martin Heinrich of New Mexico and Kamala Harris of California, in a letter released Tuesday addressed to Director of National Intelligence Dan Coats.

Trump to Meet Putin Again Next Month After Another White House Reversal
Bolton had said second summit would come after Mueller ends his election probe

President Donald Trump and Russian President Vladimir Putin arrive for a joint press conference after their summit in July in Helsinki, Finland. (Chris McGrath/Getty Images)

Donald Trump and Russian President Vladimir Putin will meet in Paris next month, their second one-on-one meeting this year as the Justice Department continues looking into whether the president’s 2016 campaign sought help from Moscow.

National security adviser John Bolton made the announcement — another reversal from the White House — in Moscow, where he has been meeting with Russian officials about a decades-old nuclear treaty from which Trump says he intends to withdraw.

Wednesday Won’t Be Your Average Recess Hump Day
Rosenstein testimony, Senate Judiciary, Trump rally to showcase tribal warfare

Deputy Attorney General Rod Rosenstein will be interviewed by the leaders of two House committees on Wednesday, part of a busy time at the Capitol and White House. (Bill Clark/CQ Roll Call file photo)

Embattled Deputy Attorney General Rod Rosenstein finally testifies. The Senate Judiciary Committee will continue its autumn of discontent. And President Donald Trump will sign opioids legislation before taking his midterms road show to Wisconsin.

No, Wednesday will not be your typical recess day. Rather, it will be a cable news bonanza chronicling the country’s era of tribal political warfare.

Health Industry Reports Lobbying Costs the Size of a Grapefruit — Drugmakers Lead
Expenses on track to surpass 2017 numbers

Pharmacist Hank Wedemeyer fills prescriptions as generic diabetes medicine awaits distribution at a community health center for low-income patients on December 1, 2009 in Aurora, Colorado. (John Moore/Getty Images)

Prescription drugmakers are on track to exceed their lobbying spending from last year, according to third quarter disclosure forms that were due Monday.

In 2017, the industry spent $171.6 million. During the first half of 2018, drugmakers spent almost $95.4 million, putting them on pace to top last year’s total.